- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
BioHarvest Sciences Inc. Common Stock(BHST)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BHST
11/13/2026: BHST (1-star) is currently NOT-A-BUY. Pass it for now.
BioHarvest Sciences Inc. is a small-cap biotechnology and packaged foods company that utilizes a proprietary botanical synthesis platform to manufacture active plant-based molecules without growing whole plants. The company's main strengths lie in its clinically validated flagship health supplement, VINIA, and its emerging business-to-business CDMO services. Its primary growth story centers on scaling production for high-value fragrance and specialty ingredient partnerships alongside direct-to-consumer expansion. However, the company faces notable financial execution risks, persistent net operating losses, and micro-cap share volatility. The stock is best suited for growth-oriented investors willing to accept high risk in exchange for potential upside from emerging synthetic biology applications.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company offers rapid top-line scaling driven by innovative cellular agriculture and high-growth CDMO expansion. |
| Momentum investor | Strong fit while signal remains positive | The stock can experience sharp upside price movements driven by positive clinical milestones or new commercial contract announcements. |
| Value investor | Weak fit | The company currently reports net losses and lacks the earnings history required for traditional value metrics. |
| Dividend investor | Weak fit | BioHarvest does not pay dividends, retaining all cash to fund business expansion and technology development. |
| Low-risk investor | Weak fit | High share price volatility and early-stage small-cap operational risks expose investors to substantial downside fluctuations. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Small market capitalization and thin trading liquidity frequently result in sharp intraday and multi-week price swings. |
| Valuation risk | Medium / high | Because the company is not yet consistently profitable, valuations depend heavily on forward revenue projections and execution. |
| Competition risk (synthetic biology and wellness brands) | Medium | Competitors ranging from traditional supplement makers to emerging biotech firms contest market share in functional ingredients. |
| Business quality | Medium | Proprietary technology gives the firm strong scientific differentiation, but full commercial maturity is still underway. |
| Dividend income | Low / none | No cash dividends are distributed to shareholders. |
| Execution risk | High | Success relies heavily on scaling production yields, fulfilling complex CDMO agreements, and achieving targeted operational breakeven. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 34.12M USD | Price to earnings Ratio - | 1Y Target Price 9.25 |
Price to earnings Ratio - | 1Y Target Price 9.25 | ||
Volume (30-day avg) 25.7K shares | Beta 1.29 | 52 Weeks Range 1.37 - 7.59 | Updated Date 11/15/2026 |
52 Weeks Range 1.37 - 7.59 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
Sector & Industry Intelligence
Sector
Consumer Defensive
Defensive- Sentiment
- Correction Expected
- Momentum
- BUY Breadth Improving
- BUY participation
- 95.0%
- Active BUY / eligible
- 19 / 20
- 30-Day BUY Count Change
- +13
- Market state
- Correction Expected
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Industry classification is unavailable for this snapshot.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -17.19% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Nutraceutical Products (VINIA) | Direct-to-consumer and retail sales of plant-derived dietary supplements utilizing red grape cells. | Provides steady, recognizable consumer brand revenue through online health and wellness channels. |
| CDMO Services & Fragrance Programs | Contract development, custom molecule production, and supply agreements for partner companies in fragrance and therapeutics. | Offers high-value business-to-business growth catalysts through custom manufacturing contracts. |
| Geographic Exposure (North America & Israel) | Operations spanning R&D facilities in Israel and primary commercial sales execution in North America. | Primarily captures consumer demand from Western wellness markets while maintaining lower-cost engineering roots. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 153.85 | Enterprise Value 33.59M | Price to Sales(TTM) 0.96 |
Enterprise Value 33.59M | Price to Sales(TTM) 0.96 | ||
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA -10.25 | Shares Outstanding 22.67M | Shares Floating 19.32M |
Shares Outstanding 22.67M | Shares Floating 19.32M | ||
Percent Insiders 14.77 | Percent Institutions 7.6 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

